Cargando…
The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct
BACKGROUND: It is hypothesized that in individuals without clinical cardiovascular disease (CVD), but at increased CVD risk, a 50% to 60% reduction in CVD risk could be achieved using fixed dose combination (FDC) therapy (usually comprised of multiple blood-pressure agents and a statin [with or with...
Autores principales: | Joseph, Philip, Pais, Prem, Dans, Antonio L, Bosch, Jackie, Xavier, Denis, Lopez-Jaramillo, Patricio, Yusoff, Khalid, Santoso, Anwar, Talukder, Shamim, Gamra, Habib, Yeates, Karen, Lopez, Paul Camacho, Tyrwhitt, Jessica, Gao, Peggy, Teo, Koon, Yusuf, Salim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299262/ https://www.ncbi.nlm.nih.gov/pubmed/30342297 http://dx.doi.org/10.1016/j.ahj.2018.07.012 |
Ejemplares similares
-
Novel Esomeprazole Magnesium-Loaded Dual-Release Mini-Tablet Polycap: Formulation, Optimization, Characterization, and In Vivo Evaluation in Beagle Dogs
por: Kwon, Taek Kwan, et al.
Publicado: (2022) -
In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events
por: Dans, Antonio L., et al.
Publicado: (2010) -
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
por: Bosch, Jackie, et al.
Publicado: (2021) -
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
por: Chow, Clara Kayei, et al.
Publicado: (2020) -
The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges
por: Eikelboom, John, et al.
Publicado: (2022)